Details of the Drug Reposition

General Information of This Drug (ID: DM3C9F8)

• Drug Name: RVT-505 (DM3C9F8)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Atopic dermatitis	DISTCP41	EA80	Phase 2	[1]
Psoriasis vulgaris	DIS6M7AN	EA90	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)